Nexus Dx
Nexus Dx offers point-of-care diagnostic products and the Nexus IB10 Analyzer, designed for professional use in various medical settings, with CE-IVD-marked products approved for use in the European Economic Area.
Point-of-Care Diagnostic Products
Nexus Dx offers a comprehensive range of point-of-care diagnostic products. These include tests for Troponin-99, NT-proBNP, D-Dimer, TSH, 3-in-1 Cardiac, beta-hCG, SOB, PCT, and penKid. These products are specially designed for professional use in hospital central laboratories, emergency departments, critical care units, and other near-patient testing locations. The point-of-care tests aim to provide quick and accurate results to support immediate clinical decision-making.
Nexus IB10 Analyzer
The Nexus IB10 Analyzer is a rapid point-of-care instrument provided by Nexus Dx. This analyzer delivers test results within 20 minutes, significantly aiding in time-sensitive clinical settings such as emergency departments and critical care units. The versatility and efficiency of the Nexus IB10 Analyzer make it an essential tool for healthcare professionals who need fast and reliable diagnostic data.
European Economic Area Compliance
All point-of-care diagnostic products based on the Nexus IB10 technology are CE-IVD-marked, indicating compliance with the European In Vitro Diagnostic Directive. These products are approved for professional use within the European Economic Area. However, it is important to note that no in vitro diagnostic product based on the Nexus IB10 technology is available for distribution in, or delivery to, the United States of America or Canada.
Headquarters
Nexus Dx is headquartered at 6759 Mesa Ridge Rd., San Diego, CA 92121, USA. This location serves as the primary base for the company's operations, which focus on the development, manufacturing, and distribution of its point-of-care diagnostic products.